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Available online 14 March 2019Background: There are suggestions that denser network connectivity (i.e., the strength of associations between
individual symptoms)may be a prognostic indicator of poor treatment response in depression.We sought to ex-
amine this aspect of depressive symptomnetworks in the context of early responses to treatment in adolescents.
Methods: Routine psychiatric data were obtained for child/adolescent service users who underwent at least three
treatment sessions in publicly funded services in England between 2011 and 2015 (N=3017, 78% female; mean
age [SD]=14.43 years [1.75]). Depressive symptomswere assessedusing theRevisedChildren's Anxiety andDe-
pression Scale at presentation, and again after three treatment sessions. Treatment response was determined
using the Reliable Change Index. Network analysis was used to compare the depressive symptom structure
and connectivity of sub-samples who, after three treatment sessions had: 1) positively responded (n = 566),
2) not reliably changed (n = 2277), and 3) reliably deteriorated (n = 174), using matched samples to control
for baseline severity.
Findings: Overall connectivity (i.e., the summed total of weighted connections) was signiﬁcantly weaker for the
positive treatment response group at baseline (compared with unchanged and deteriorated groups), however,
this group saw the largest increase in connectivity over the course of treatment.With regard to the overall impor-
tance of speciﬁc symptoms within the networks, fatigue was highest in strength for the unchanged and deterio-
rated groups, whereas low mood was highest in strength for the improved group.
Interpretation: This study demonstrates that adolescents who respond early to treatment for depression are
characterised by symptom networks that are less densely connected initially, yet increase in connectivity over
the course of treatment. This may be indicative of ‘positive spirals’whereby improvement in one symptom trig-
gers improvements in other symptoms, thereby increasing symptom–symptom associations even as severity de-
creases.
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Depression is the most prevalent and burdensome form of psycho-
pathology [1–3], with low recovery rates in treatment and high levels
of recurrence throughout the lifecourse [4,5].
Despite decades of research into the aetiology, assessment and treat-
ment of depression, we have limited knowledge of the clinical charac-
teristics that differentiate between those who do and do not respond
to treatment. It has been suggested that part of this lack of scientiﬁc
progress may be attributed to our conceptualisation ofunder the CC BY-NCpsychopathology, with categorical diagnostic systems failing to ade-
quately capture the inherent complexity of depression [6].
The network approach is a recently developed alternative that em-
braces the heterogeneity within psychiatric constructs. Rather than
focus on underlying ‘disorders’, this approach seeks to conceptualise
and understand psychopathology as a complex network of locally asso-
ciated symptoms. Whilst network theory is an increasing area of focus
in psychiatric research there is still much debate about how best to
use and interpret symptom networks [7–9].
Connectivity (i.e. the strength of the associations that exist between
symptoms) is an aspect of the network approach that may be informa-
tive in the study of prognosis and treatment response. Indeed, it has
been suggested that individuals with strongly associated symptom-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Research in context
Evidence before this study
The network approach is a novel conceptualisation of psycho-
pathology symptoms and it has been suggested that this approach
might help understand responsiveness to treatment. This ap-
proach suggests that psychiatric disorders are the result of causal
interplay between individual symptoms,whereby symptoms feed
into each other and eventually settle into a mutually reinforcing
state.We searchedMEDLINE, PsychINFO, and PubMed for studies,
that used network analysis to explore group-level differences in
those who did and did not respond to treatment for depression,
published in English and after 2010 (when network models of
psychopathology ﬁrst emerged) and searched papers that cited
the relevant studies found. We identiﬁed only two studies that
both investigated longer term treatment response and depressive
symptom networks. The ﬁrst study found evidence that network
connectivity (i.e. the overall strength of associations between in-
dividual symptoms) was higher at baseline for those who had
persistent depression after two years compared with those who
remitted. As such, it was suggested that more strongly associated
symptomsmay lead to a poorer prognosis, reﬂectingmaladaptive
feedback cycles that are difﬁcult to break. However, a conceptual
replication of this study found no such evidencewhen they exam-
ined the symptom connectivity of adolescents who did and did
not respond to treatment. We found no previous studies explor-
ing network connectivity and short-term responses to treatment.
Added value of this study
To the best of our knowledge, we are the ﬁrst study to explore
whether network connectivity is associated with early responses
to treatment for depression in adolescence. Second, we utilise a
considerably larger clinical sample than the two published studies
in this area, and a more reliable approach to determining treat-
ment response. Third, previous studies have only compared net-
works at baseline, whereas we also explore how these networks
change over the course of initial treatment.
Implications of all the available evidence
Our ﬁndings suggest that those with more densely connected
symptom networks at baseline are less responsive to treatment in
the short-term. Moreover, we found that, for those who demon-
strated early positive response to treatment, symptom networks
increased in overall connectivity over the course of treatment
and changes in individual symptoms indicate uniform improve-
ment across all symptoms. This might suggest ‘positive feedback
loops’, whereby improvements in one symptom may lead to im-
provements in others.
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severity of symptoms [10]. Based on this theoretical andmethodological
approach as conceptualised to-date, at the group-level, this would be
reﬂected in: i) a treatment-resistant group with a symptom network
that is densely connected, and ii) a treatment-responsive group with a
less densely connected symptom network. The increased connectivity
in the treatment resistant group could potentially reﬂect stronger dy-
namic interplay and reinforcement amongst symptoms, shared risk fac-
tors (e.g. genetic predisposition or environmental factors inﬂuencing
multiple symptoms simultaneously) or a combination of both.
However, to date, only two studies have examined symptom net-
works and differences in treatment prognosis in cases of depression.These studies have both focussed only on baseline connectivity and
long-term outcomes, and to date, no research has examined network
connectivity as a prognostic factor in of early treatment response.
Using data from a prospective study of adult psychiatric patients (N
= 515), Van Borkulo and colleagues [10] compared the network struc-
tures of those with remittent and persistent depression (N = 515;
assessed at a 2-year follow up), and found that baseline connectivity
was stronger in participants with persistent depression. In a conceptual
replication, Schweren and associates [11] found no difference in base-
line connectivity for adolescents who differed by treatment response
(N= 465, average months in treatment = 22).
Given the increased visibility of network models in the literature,
further research is required to determinewhether network connectivity
can convey important information regarding prognosis and treatment
responsiveness. The present study expands on previous work in several
important ways. First, the two previous studies [10,11] focussed their
enquiries on groups that differed in their long-term prognostic out-
comes. The present study seeks to determine whether group-level con-
nectivity differs in the context of early responses to treatment. Second,
the studies of van Borkulo et al. [10], and Schweren et al. [11], relied
on relatively small samples, and blunt means of classifying treatment
responders/non-responders (e.g. median split at follow-up assess-
ment). In the current studywe extend upon the two previous investiga-
tions by comparing the overall connectivity and structure of depressive
symptom networks in a large clinical sample of children and adoles-
cents, and we use a more robust means of classiﬁcation, the reliable
change index (RCI) [12,13], to deﬁne the extent towhich overall depres-
sive symptoms changed over three sessions of treatment. The reliable
change index permits examination of change in symptoms that is larger
than that expected based on measurement error, and hence is a more
robust approach to identify groups of individuals that have responded
to treatment compared to using median split or raw change scores.
Third, there is increased evidence that group-level connectivity can
change during the course of illness and in response to treatment [14,
15], yet the two previous studies examined differences in connectivity
at baseline only. We expand on previous work by not only examining
differences between networks at baseline, but also differences between
these networks during treatment, and within-network differences over
the course of treatment. Furthermore, we conduct exploratory analyses
in which we compare the overall importance of speciﬁc symptoms (i.e.
symptom centrality) across treatment groups in order to identify symp-
toms that may be particularly inﬂuential in different groups based on
their early treatment response.
2. Methods
2.1. Participants
This study used routinely collected psychiatric assessment data from
a national best-practice initiative in the UK between 2011 and 2015.
Symptom-level data were collected at 81 Child and Adolescent Mental
Health Services (CAMHS) operated by the National Health Service
(NHS), local authority and voluntary sector providers [16]. Being a rou-
tine clinical database there was considerable heterogeneity in the as-
sessment measures used, treatment strategies implemented, and
duration of treatment. Given the focus on depressive symptoms in this
study, we started by selecting all individuals aged 8–18 year olds receiv-
ing psychological treatment, who had been assessed using the Major
Depressive Disorder subscale of the Revised Child Anxiety and Depres-
sion Scale (RCADS), and who had complete symptom data available.
Based on these criteria, a total of 8238 children underwent routine as-
sessment and at least 1 treatment session, 4687 completed at least 2 as-
sessment/treatment sessions, and 3017 completed at least 3
assessment/treatment sessions. We chose to focus our analysis on the
latter group (78% female; mean age [SD]= 14.43 [1.75]), as three treat-
ment sessionswere judged to be an adequate amount of time to observe
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sample [16]. Compared with those who only underwent one session,
our retained sample had a higher proportion of females (X2 [1] =
148.33, p b 0.01), and were slightly older (mean difference =
8.28 months; t[7910] =−14.95, p b 0.01). Those who were and were
not retained in the sample did not differ in terms of their overall level
of depressive symptomatology (t[1033] = 0.43, p= 0.66). In our sam-
ple, 58% of individuals were white, 2.4% were of mixed race, 2.1% were
Asian, 2.1% were black, 4.4% were from other ethnic groups, and 31%
did not have their ethnicity recorded. The mean time between ﬁrst
and last third treatment session was 99.11 days (SD = 98.31; Median
= 60.79; Range = 3–882). The types of psychological treatments re-
ceived varied considerably for participants, and this information was
missing for the majority of the participants (N70%); therefore, we did
not examine effects stratiﬁed by treatment type. The data used in this
study are service user records and speciﬁc ethical permission was not
required to conduct this analysis. Children and/or parents who pre-
sented for treatment at any of the participating CAHMS providers
were asked to sign a consent form indicating that they were happy to
have their routine outcome information shared. This form outlined the
purposes for collecting such data, the anonymity and data security pro-
cedures employed, the voluntary nature of initiative, and their right to
withdraw at any time. Approval for this study was granted by the re-
view board of the institution that hosts the data, The Child Outcomes
Research Consortium (CORC; https://www.corc.uk.net/), and all data
management and conﬁdentiality protocols governing the use of the
dataset were followed.
2.2. Data Statement
Due to the strict conﬁdentiality protocols surrounding this service
user data, the data cannot be shared freely. The correlation matrices
used to estimate the networks are available upon request.
2.3. Measure of Depressive Symptoms
Symptoms of depression were routinely measured using the Major
Depressive Disorder subscale of the Revised Children's Anxiety and De-
pression Scale (RCADS) [17]. This subscale consists of 10 items scored
from Never (0) to Always (3), which are summed to form total severity
score (maximum of 30).
2.4. Reliable Change
We used the RCI [12,13] to divide cases into groups based on the
change in scores from the ﬁrst (T1) to the third (T3) treatment session.
The RCIwas calculated using the formula in Jacobson& Truax [12], using
the standard deviation and Cronbach's alpha of scores at the ﬁrst ses-
sion, resulting in identiﬁcation of changes that were unlikely to be due
to measurement error alone (RCI = x2− x1 / Sdiff). After applying this
formula to the current dataset, itwas calculated that changes in total de-
pression scores of ±6.3 were indicative of reliable improvement or de-
terioration. Three groups were identiﬁed using the RCI; i) reliably
improved (n = 566, 78% female), ii) no reliable change (n = 2277,
77% female), and iii) reliably deteriorated (n = 174, 81% female).
These groups did not differ in terms of age (F (2, 3014) = 0.84, p N
0.05), gender χ2 (2) = 1.92, p N 0.05, or length of time in treatment (F
(2, 3014) = 2.31, p= 0.09).
2.5. Statistical Analysis
A one-way ANOVA with Tukey post-hoc comparisons was used to
compare the overall severity of depressive symptoms (i.e. summed
total scores) at T1 and T3. Regularised partial correlation networks
were estimated separately at T1 and T3 for each of the three groups
using the ‘qgraph’ package in R [18]. This package visualises networksas nodes (i.e. points in space that in this case represent symptoms),
and edges (i.e. lines linking symptoms). In weighted undirected net-
works such as these, the edges can be interpreted as partial correlation
coefﬁcients, with the thickness of each line reﬂecting the strength of the
association between two symptoms. Each networkwas visualised using
the ‘spring’ layout, which places strongly connected symptom nodes
closer together [19]. To account for the large number of parameters es-
timated in a typical network, ‘qgraph’ employs a least absolute shrink-
age and selection operator (lasso) to shrink edges and set very small
edges to zero, thus reducing the likelihood of false positives [19]. The
importance of each individual symptomwithin the context of the over-
all networkwas assessed using two commonmeasures of node central-
ity; strength (sum ofweighted connections) and betweenness (number
of times a node lies on the shortest path between two other nodes) [20].
Strength can be considered an indicator of how strongly a symptom is
directly associated with other nodes in the network, whereas between-
ness highlights how important a symptom is in bridging unconnected
symptoms in the network. To determine the extent to which the rank
ordering of the edge weights in the networks could be considered reli-
able, bootstrapped difference tests were performed using the R package
‘bootnet’ [19]. This procedure takes the observed difference in edge
values and constructs bootstrapped 95% conﬁdence intervals (CIs)
around these values. If the 95% CI crosses zero, this suggests the edges
are not statistically different [19]. The stability of the centrality indices
was examined using the case-dropping subset bootstrap method; net-
works were re-estimated using increasingly smaller subsets of the orig-
inal sample, and correlations between the original centrality indices and
the subset centrality indices were calculated. A small-to-moderate de-
crease in correlation as participants are removed suggests that the
order of centrality is relatively stable/reliable [19].
Networks were compared based on overall connectivity (the
summed total of weighted connections, aka global strength) and overall
structure using the ‘NetworkComparisonTest’ (NCT) package [21]. This
procedure is carried out in three phases. First, the two networks in ques-
tion are estimated and the relevant test statistics are calculated. For in-
variance in overall connectivity, the test statistic is the difference in
global-strength (i.e., difference in sum of edge weights of two net-
works). For structural invariance, the statistic is the largest individual
difference in edge strength observed between the two networks. Sec-
ond, cases are repeatedly and randomly swapped between networks,
and these test statistics re-estimated. Third, a reference distribution is
created from these test statistics and statistical signiﬁcance is deter-
mined (i.e. whether the observed statistic falls within the 95th percen-
tile for a signiﬁcance level of 0.05) [10]. Networkswere compared using
1000 random permutations. We compared networks across groups at
baseline (improved v unchanged, unchanged v deteriorated, improved
v deteriorated), and within groups over treatment, meaning a total of
6 network comparisons for conducted. The Benjamini–Hochberg [22]
procedure was employed to account for multiple comparisons. Empiri-
cal comparisons of the structure and connectivity of symptomnetworks
may be inﬂuenced by symptom severity [10], and those who are closer
to the extremes of score distributions at baseline aremore likely to dem-
onstrate reliable changes in scores over time, i.e. regression towards the
mean [23]. Moreover, network comparison procedures may also be in-
ﬂuenced by the sample size of the compared groups [10]. As such, to en-
sure that group-level differences in network structure/connectivity
were not driven by baseline severity scores, and to derive equally
sized groups, we compared the networks of subgroups that were
matched on baseline depressive severity scores. Propensity score
matching [24] was used to conduct threematched comparisons at base-
line: i) improved group (n = 566) v matched controls from the un-
changed group (n = 566), ii) deteriorated group (n = 174) v
matched controls from improved group (n= 174), and iii) deteriorated
group (n = 174) v matched controls from unchanged group. Matching
was conducted using the ‘nearest neighbour’ method in the ‘MatchIt’
[25] package.
Table 1









Δ Global Strength Value
T1–T3
Full samples
Reliably Improved (n = 566) 20.05 (4.89) 9.72 (5.16) 3.42 4.15 0.72⁎
No Reliable Change (n = 2277) 17.30 (5.87) 16.44 (6.34) 4.13 4.32 0.19⁎
Reliably Deteriorated (n = 174) 12.99 (5.16) 22.46 (4.8) 3.80 3.89 0.09
Matched samples
No Reliable Change Matched to Reliably Improved (n = 566) 20.05 (4.89) – 3.77 – –
No Reliable Change Matched to Reliably Deteriorated (n = 174) 12.99 (5.16) – 3.93 – –
Reliably Improved Matched to Reliably Deteriorated (n = 174) 12.99 (3.52) – 0.53 – –
⁎ Difference signiﬁcant at p b 0.01 level.
32 E. McElroy et al. / EClinicalMedicine 8 (2019) 29–363. Results
Mean scores on the RCADS depression subscale are presented for
each group in Table 1. At baseline, the reliably improved group had sig-
niﬁcantly higher scores than the no reliable change group,which in turn
scored signiﬁcantly higher than the deteriorated group (F(2, 3014) =
113.91, p b 0.01). At T3 the reverse pattern was observed (F(2, 3014)
= 400.19, p b 0.01). The matching procedure resulted in perfect 1–1
matches; i.e. participants from the smaller groups were matched with
participants from the larger groups who had the same total RCADS de-
pression scale scores at T1 (Table 1). Item-level means at T1 and T3
are presented for each group in Fig. 1 (for standard deviations, see
Table S1, available online). There were consistent decreases in meansFig. 1.Mean item scores at baseline and following treatment. Sad = Feels sad or empty;
Anh = Anhedonia; Slp = Trouble sleeping; App = Problems with appetite; Ftg =
Fatigue; Tir = Tired a lot; Thk = Cannot think clearly; Wrt = Feels worthless; Lth =
Lethargy; Rst = Feels restless.across all items for the improved group, and similarly consistent in-
creases for the deteriorated group.
3.1. Network Comparisons at Baseline
The network diagrams for the different groups, based on matched
samples at T1, are presented in Fig. 2, and global strength values
(i.e., overall connectivity) are presented in Table 1.
At baseline, the improved group had a less strongly connected net-
work than matched samples from the unchanged (n = 566, Δglobal
strength = 0.36, p = 0.045) and deteriorated (n = 174, Δglobal
strength = 3.25, p = 0.009) groups, and these remained signiﬁcant
after applying the Benjamini–Hochberg correction. A matched sample
from the unchanged group did not differ signiﬁcantly from the deterio-
rated group at baseline (n = 174; Δglobal strength = 0.13, p= 0.62).
3.2. Network Comparisons Over Treatment
Connectivity increased for all three groups between T1 and T3, how-
ever this change was not signiﬁcant for the deteriorated group, possibly
reﬂecting lower statistical power (Table 1). In order to further explore
where these changes in connectivity were localised, networks were es-
timated using item-level change scores (i.e. scores at T1 subtracted from
scores at T3), and these networks are presented in the online supple-
mentary materials (Fig. S1). These change score networks demonstrate
that the associations between certain symptom pairs changed to a
greater degree than others in the improved and unhanged groups, de-
spite the fact that item level changes in severity were fairly uniform
(Fig. 1). The NCT did not observe any signiﬁcant differences in structure
within the groups, suggesting that the overall structures of the networks
(i.e., which symptomsweremost strongly associatedwith one another)
remained broadly consistent across treatment.
3.3. Centrality: Relevance of Individual Symptoms in the Network
Centrality indices are presented in Fig. 3. At baseline, fatigue was
highest in strength for the unchanged and deteriorated groups, whereas
for the improved group, low mood had the highest strength.
Comparedwith the strength values, betweenness values (number of
times a symptom mediates the association between two other symp-
toms) were more variable across groups. Fatigue had the highest be-
tweenness for the unchanged group at T1 and T3, but not for the
improved or deteriorated groups.
3.4. Network Accuracy/Stability
The bootstrapped difference tests of accuracy and stability are pre-
sented in the supplementary material (Figs. S2–S13). The unchanged
and improved networks demonstrated excellent accuracy and stability,
and the deteriorated group demonstrated moderate accuracy and sta-
bility (reﬂecting smaller n). As such the strength of edge weights and
rank ordering of centrality can be interpreted with greater conﬁdence
Fig. 2.Network diagrams in thematched samples at T1. For ease of visual comparison, the layout from the overall sample (N=3017) at T1 is used consistently throughout. Sad=Feels sad
or empty; Anh=Anhedonia; Slp=Trouble sleeping; App=Problemswith appetite; Ftg= Fatigue; Tir= Tired a lot; Thk=Cannot think clearly;Wrt=Feelsworthless; Lth= Lethargy;
Rst = Feels restless.
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vised for the deteriorated group.
4. Discussion
This study demonstrates hownetworkmodelsmay be used to better
our understanding of symptom connectivity in disorder progression
and treatment response. We aimed to replicate and extend ﬁndings of
two previous studies [10,11] utilising a larger clinical sample, amore ro-
bust means of categorising those who may be considered responders
and non-responders to treatment and examining change in network
connectivity and corresponding symptom severity over treatment [12,
13]. We found that independent of symptom severity, the strength of
associations (or connectivity) between depressive symptoms is associ-
ated with treatment response. Children/adolescents who demonstrated
an early positive response to treatment had a less densely connected
symptom network at baseline compared with matched samples ofchildrenwho remained unchanged or deteriorated, replicating one pre-
vious study in adults [10]. To further understand theutility of investigat-
ing network structure and connectivity in understanding treatment
response and progress, we examined changes in network structure
alongside treatment sessions and found that network connectivity in-
creased in those with improved symptom severity. It also increased in
those with unchanged symptom severity but to a lesser extent. Similar
observations of increasing connectivity following treatment have been
reported elsewhere [15,26]. However, researchers have struggled to in-
terpret this ﬁnding [26], as the prevailing narrative has been that higher
connectivity is a function of greater severity; i.e., symptoms inﬂuence
each other and increase overall severity in a negative spiral of reinforc-
ing symptom severity. This has been conceptually illustrated using ex-
amples such as insomnia → fatigue → concentration problems →
psychomotor problems [27]. Such ‘negative spirals’ have been framed
within the clinical staging model [28], whereby disorders progress
from subclinical symptoms to chronic and severe pathology, with
Fig. 3. Centrality indices by group. Sad= Feels sad or empty; Anh= Anhedonia; Slp = Trouble sleeping; App= Problems with appetite; Ftg = Fatigue; Tir = Tired a lot; Thk= Cannot
think clearly; Wrt = Feels worthless; Lth = Lethargy; Rst = Feels restless.
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[29]. In light of this framing, a possible explanation for our observed
ﬁndings of increased connectivity alongside decreased symptom sever-
ity is that the reverse could plausibly occur; i.e., ‘positive spirals’
whereby improvement in one symptom leads to an improvement in an-
other symptom (e.g. decreased sleep problems → increased energy
levels and motivation). With this hypothesised explanation although
overall severity in symptomswould decrease, the associations between
symptoms might increase in the treatment-responsive population. In
the present study, the higher increased connectivity observed in the re-
liably improved group could be interpreted as supportive of this idea,
and may explain why an increase in connectivity between symptoms
can be found even as overall severity decreases [15,26].
Another possible explanation that has been proposed to explain the
higher increased connectivity observed in the group responsive to treat-
ment is a change in the interpretation of items and how they relate to
one another due to the therapeutic effects of psychological treatment
(response shift bias) [15]. Furthermore, it has been suggested that
group-level differences in connectivity may be explained by differences
in item variances [30]. Indeed, recent studies have found that the vari-
ance of symptoms increased as the severity of depressive symptoms de-
creased in response to treatment [14,15]. However, in the present study,
we found that, with the exception of one symptom (‘Feels tired’), items
in the improved group (which saw the only signiﬁcant increase in con-
nectivity) decreased slightly in variance over the course of treatment.
Thus, this explanation does not explain the increased connectivity ob-
served in the improved group and this cannot be attributed to increased
variance in these data.
We further explored changes in network structure and connectivity
over treatment by estimating networks based on change scores. The
change network for the improved group was sparse with few connec-
tions. This demonstrates that, although the mean-level severity of
symptoms decreased in a fairly uniform way over treatment, changes
in the associations between items were not consistent. This lendssupport to the possibility of positive spirals of symptom improvement
that might occur in response to treatment in some individuals leading
to improvement in overall levels of depression. As such, this highlights
that it is crucial to interpret changes in network structure together
with changes in symptom-level severity. In order to accurately capture
such symptom improvement or deterioration spirals, further research
employing designs that collect repeated measures over short intervals
(i.e., experience sampling method) is required [31].
The reliably deteriorated group identiﬁed in the present study did
not see an increase in overall connectivity over treatment which does
not support the expectation that increased connectivity might help ex-
plain increased overall severity. It is important to note the smaller sam-
ple size of this group, and future research with larger samples would
beneﬁt from further investigating the characteristics of those who dete-
riorate during treatment. As for the unchanged group, a small increase
in overall connectivity was observed, possibly reﬂecting shifts towards
recovery or deterioration that was occurring at a slower rate, and as
such had not (yet) resulted in meaningful clinical change in symptom
severity.
Along with overall connectivity, the present study explored differ-
ences in the importance of individual symptoms in the various treat-
ment response groups, focussing on the strength centrality (i.e. how
strongly a symptom was directly associated with all other symptoms)
[19]. Across all three treatment response groups, there was consistency
in the relative strength values of different symptoms. Fatigue was par-
ticularly high in strength for all three groups at both time points. This
ﬁnding is in line with previous studies, using adult samples, which
have highlighted fatigue and lethargy/psychomotor retardation as
highly central symptoms in cases of depression [10,32,33]. Investigating
the rank ordering of centrality values, we observe that the fatigue symp-
tom was highest in strength for both the unchanged and deteriorated
group, whereas for the improved group the symptom ‘sad/low mood’
had the highest strength. Tentatively, this suggests that fatigue might
be a core symptom amongst those who do not respond to treatment.
35E. McElroy et al. / EClinicalMedicine 8 (2019) 29–36This not only offers a plausible mechanism for the persistence of symp-
toms over treatment (i.e. fatigue/lethargy impeding efforts to success-
fully implement treatment strategies), but also suggests an area for
direct intervention, for instance with treatments aimed speciﬁcally at
reducing fatigue, particularly in cases of chronic depression. To the
best of our knowledge, research has not yet explicitly examined the ef-
fect of intervening on highly central symptoms (comparedwith periph-
eral symptoms, or construct-level interventions), however this could be
a promising area for further enquiry.
The main strengths of the present study were the large clinical sam-
ple, the use of a robust means of classifying individuals based on their
response to treatment, and the use of a well-validated clinical measure
of depressive symptomatology. As a result of using reliable change in
symptom severity to determine treatment responsiveness, a small pro-
portion of individuals were identiﬁed as having reliably deteriorated
during the course of treatment. This group is expected to exist in usual
treatment settings [16], but has not been studied to-date in the context
of psychopathological networks [10,11]. It is important to note that this
deteriorated group had a smaller sample size, meaning less reliable in-
formation about their symptom networks is available. By using propen-
sity score matching to match groups on baseline symptom severity, we
can be conﬁdent that these ﬁndings are not just reﬂecting differences
between groups in baseline severity. With regard to limitations, ﬁrst,
due to considerable missingness and heterogeneity in treatment data,
we lacked the data to factor into our analysis the type of treatment un-
dergone. It also remains possible that responsiveness may have differed
as a function of treatment type [14]. Second, there were no data avail-
able on any co-administered psychopharmacological treatments, and
recent evidence suggests such treatments can alter the structure of
symptom networks [14]. Third, given the study used real-world routine
psychiatric data, the length of treatment varied for each individual.
Fourth, the major depression subscale of the RCADS contains one item
(‘Appetite problems’) which likely encompasses opposing symptom-
atology (i.e., eating too much/not enough), which makes it impossible
to disentangle unique associations for these symptoms. Fifth, although
co-morbidity is common and studying the symptom networks of any
co-morbid conditions might be informative, routinely collected symp-
tom data on any potential co-morbidities were unavailable. That is be-
cause in routine care it is unfeasible and uncommon to collect several
outcome measures routinely from each service user. Finally, it must be
noted that the networks reported in the present study were cross-
sectional/between-participant networks. Whether ﬁndings from such
networks can be generalised to the level of the individual remains to
be determined [34].
In conclusion, using a large clinical samplewe demonstrated that in-
dividualswhowere themost responsive to treatment over a small num-
ber of sessions had a less densely connected symptom network at
baseline, and this symptom network increased in connectivity over
the course of treatment. Fatigue was higher in centrality for those who
did not respond positively to treatment (compared with those who
did), suggesting it might play a key role in determining treatment re-
sponse. For thosewho reliably improved over theﬁrst three sessions, in-
creases in connectivity may be the result of positive spirals, whereby
improvements in one symptom inﬂuences other symptoms in the net-
work, thus increasing symptom connectivity over treatment course.
This ﬁnding suggests that treatment response may not simply be deter-
mined by how severe symptoms are throughout treatment, but also
how these symptoms are associated and how these associations change
over time.
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